Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Clinical and Molecular Hepatology. 2023;29(Suppl):S123-S135 
Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease
Liver International. 2011;31(4):461-473
Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Non-invasive tests are enough
Liver International. 2018;38:67-70
Steatosis affects the sensitivity but not the specificity of non-invasive fibrosis tests in non-alcoholic fatty liver disease - implications for screening strategies
Liver International. 2018;38(2):224-226
Noninvasive Evaluation of Fibrosis and Steatosis in Nonalcoholic Fatty Liver Disease by Elastographic Methods
Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018;
Non-alcoholic fatty liver disease pathogenesis: The present and the future
Digestive and Liver Disease. 2009;41(9):615-625
P.04.16 NON INVASIVE FIBROSIS AND FATTY LIVER ASSESSMENT IN NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN REAL LIFE
Digestive and Liver Disease. 2019;51:e178-e179
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and
future
Clinical and Molecular Hepatology. 2023;29(Suppl):S171-S183
A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease
Digestive and Liver Disease. 2014;46(11):1008-1013
Non-invasive Assessment of Non-alcoholic Fatty Liver Disease: Ultrasound and Transient Elastography
NAFLD and NASH. 2020;115-139